Search. Learn. Save

Platform for Pharmaceutical Products for Healthcare Professionals
Search By
☰ Generic Formulas

Generic Formulas X

Diloxanide Furoate And Metronidazole

Diloxanide Furoate and Metronidazole: A Comprehensive Overview

Introduction

Diloxanide furoate and metronidazole are two antimicrobial agents commonly used in the treatment of intestinal protozoal infections, specifically amoebiasis. Amoebiasis is caused by the parasite Entamoeba histolytica, which can lead to a variety of gastrointestinal issues, ranging from mild diarrhea to severe dysentery and liver abscesses. The combination of diloxanide furoate and metronidazole has proven to be an effective therapeutic regimen for managing both symptomatic and asymptomatic forms of the disease, as well as other protozoal infections.

1. Diloxanide Furoate and Metronidazole

1.1 Diloxanide Furoate

Diloxanide furoate is an antiprotozoal agent primarily used to treat amoebiasis, caused by Entamoeba histolytica. Unlike some other antiprotozoal drugs, diloxanide furoate has a relatively low toxicity profile and is highly effective against the luminal stage of the parasite, meaning it targets the cysts and trophozoites present in the intestines. Diloxanide furoate is often used in the eradication of asymptomatic carriers of E. histolytica, helping to reduce the transmission of the infection to others.

Diloxanide furoate works by disrupting the metabolism of the amoeba, inhibiting its growth and replication within the intestines. The drug is usually taken in combination with metronidazole for synergistic activity, as metronidazole targets other stages of the parasite, such as the invasive trophozoites that cause clinical disease.

1.2 Metronidazole

Metronidazole is a broad-spectrum antimicrobial agent that is primarily used to treat infections caused by anaerobic bacteria and protozoa. Metronidazole has long been used in the treatment of amoebiasis, and its primary mode of action involves the inhibition of DNA synthesis in susceptible organisms. When the drug is metabolized in the anaerobic environment, it generates toxic metabolites that interfere with DNA and other cellular components of the microorganism, ultimately leading to its death.

In addition to its effectiveness against Entamoeba histolytica, metronidazole is also used for a range of other infections, including bacterial vaginosis, giardiasis, trichomoniasis, and Clostridium difficile-associated diarrhea. In combination with diloxanide furoate, metronidazole treats both the luminal and invasive stages of amoebiasis, offering a comprehensive approach to the disease.

2. Mechanism of Action

2.1 Diloxanide Furoate

Diloxanide furoate is a prodrug that is converted into its active form in the intestinal tract. Once inside the gastrointestinal system, it targets the trophozoites and cysts of Entamoeba histolytica that reside in the luminal space of the colon. Diloxanide furoate disrupts the metabolism of the parasite by inhibiting its ability to synthesize important cellular components, including proteins and lipids. This interference with cellular function leads to reduced proliferation and eventual death of the parasite, helping to clear the infection.

The drug's activity is most potent against asymptomatic carriers, individuals who harbor E. histolytica but show no signs or symptoms of the disease. By targeting the cyst and trophozoite stages in the intestine, diloxanide furoate prevents the parasite from multiplying and spreading to others.

2.2 Metronidazole

Metronidazole's antimicrobial action is based on its ability to generate reactive metabolites in anaerobic conditions. Once absorbed and metabolized by the body, metronidazole undergoes reduction by the electron transport proteins in anaerobic organisms, producing nitroso radicals that bind to and disrupt the DNA of the microorganism. This damage to the DNA leads to strand breaks and ultimately the death of the organism.

In the case of amoebiasis, metronidazole targets the invasive trophozoites of E. histolytica that have breached the intestinal wall and caused ulcerations, abscesses, or dysentery. By attacking these invasive forms, metronidazole helps to control the acute symptoms of the disease, such as diarrhea, abdominal pain, and fever. The combination with diloxanide furoate ensures that both the luminal and invasive stages of the parasite are treated.

3. Clinical Uses

Diloxanide furoate and metronidazole are used primarily in the treatment of amoebiasis, an infection caused by Entamoeba histolytica. The disease can present in several forms, ranging from asymptomatic cyst passage to severe invasive disease.

3.1 Amoebiasis

Amoebiasis is a protozoal infection caused by the parasite Entamoeba histolytica, which is transmitted through contaminated food or water. The infection can cause symptoms ranging from mild diarrhea to severe dysentery (bloody diarrhea) and liver abscesses. The disease can be either acute or chronic and may present as intestinal amoebiasis or extra-intestinal amoebiasis (e.g., liver abscess).

  • Luminal Amoebiasis: Diloxanide furoate is highly effective in eradicating the asymptomatic cyst carriers of E. histolytica, preventing the spread of the infection.

  • Invasive Amoebiasis: Metronidazole is used to treat the invasive trophozoite stage, which can cause dysentery, intestinal ulceration, and extra-intestinal complications like liver abscess.

The combination therapy of diloxanide furoate and metronidazole is typically used for both symptomatic and asymptomatic cases, providing a comprehensive approach to managing the infection.

3.2 Giardiasis

Although giardiasis is primarily caused by the protozoan Giardia lamblia, metronidazole is an effective treatment for this intestinal parasitic infection. Giardiasis can cause symptoms such as diarrhea, abdominal cramping, nausea, and bloating. Metronidazole disrupts the DNA of Giardia, eliminating the parasite and alleviating symptoms.

3.3 Trichomoniasis

Metronidazole is the first-line treatment for trichomoniasis, a sexually transmitted infection caused by the protozoan Trichomonas vaginalis. Symptoms of trichomoniasis in women include vaginal discharge, itching, and burning. In men, the infection may cause urethral discharge and painful urination. Metronidazole is highly effective in eradicating Trichomonas vaginalis.

4. Dosage and Administration

The typical dosing regimen for diloxanide furoate and metronidazole can vary based on the specific condition being treated, the patient's age, and the severity of the infection.

4.1 For Amoebiasis

  • Diloxanide Furoate: The usual dose for luminal amoebiasis in adults is 500 mg three times daily for 10 days.

  • Metronidazole: The typical dosage for invasive amoebiasis is 750 mg three times daily for 7-10 days. For extra-intestinal amoebiasis, a longer duration of treatment may be required.

The combination of these two drugs is often used to treat acute symptomatic infections (e.g., dysentery) and asymptomatic carriers.

4.2 For Other Infections (Giardiasis, Trichomoniasis)

  • Giardiasis: For giardiasis, metronidazole is usually administered at 250-500 mg three times daily for 5-7 days.

  • Trichomoniasis: For trichomoniasis, metronidazole is typically given as a single dose of 2 grams or 500 mg twice daily for 7 days.

5. Side Effects and Adverse Reactions

Both diloxanide furoate and metronidazole are generally well-tolerated, but they can cause side effects, particularly when taken for extended periods or in high doses.

5.1 Diloxanide Furoate Side Effects

  • Gastrointestinal distress (nausea, abdominal pain, diarrhea)

  • Headache

  • Rash (rare)

  • Allergic reactions (rare)

5.2 Metronidazole Side Effects

  • Gastrointestinal symptoms (nausea, vomiting, diarrhea)

  • Metallic taste

  • Headache

  • Dizziness

  • Disulfiram-like reaction when alcohol is consumed (flushing, nausea, vomiting)

6. Precautions and Contraindications

  • Pregnancy and breastfeeding: Both drugs should be used cautiously in pregnant or breastfeeding women, especially in the first trimester.

  • Liver or kidney impairment: Metronidazole should be used with caution in patients with liver impairment, while diloxanide furoate should be avoided in cases of severe liver disease.

  • Alcohol consumption: Metronidazole should not be taken with alcohol due to the risk of a disulfiram-like reaction.

7. Conclusion

The combination of diloxanide furoate and metronidazole offers a highly effective treatment regimen for amoebiasis, addressing both the luminal and invasive stages of the infection. By targeting different stages of the Entamoeba histolytica life cycle, this combination therapy provides comprehensive treatment, reducing symptoms and preventing transmission. It is crucial for clinicians to consider potential side effects, drug interactions, and contraindications when prescribing this therapy, ensuring the best possible outcomes for patients.